Nu Skin Ownership
| NUS Stock | USD 8.12 0.04 0.49% |
Shares in Circulation | First Issued 1995-03-31 | Previous Quarter 49.7 M | Current Value 49.7 M | Avarage Shares Outstanding 67 M | Quarterly Volatility 13 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
NUS |
NUS Stock Ownership Analysis
About 78.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nu Skin Enterprises has Price/Earnings To Growth (PEG) ratio of 2.35. The entity recorded a loss per share of 2.95. The firm last dividend was issued on the 24th of February 2025. Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. Nu Skin operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 4600 people. To find out more about Nu Skin Enterprises contact Ryan Napierski at 801 345 1000 or learn more at https://www.nuskin.com.Besides selling stocks to institutional investors, Nu Skin also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nu Skin's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nu Skin's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nu Skin Quarterly Liabilities And Stockholders Equity |
|
Nu Skin Insider Trades History
Roughly 3.0% of Nu Skin Enterprises are currently held by insiders. Unlike Nu Skin's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nu Skin's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nu Skin's insider trades
NUS Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nu Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nu Skin Enterprises backward and forwards among themselves. Nu Skin's institutional investor refers to the entity that pools money to purchase Nu Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | American Century Companies Inc | 2024-12-31 | 824.7 K | Qube Research & Technologies | 2024-12-31 | 740.6 K | Charles Schwab Investment Management Inc | 2024-12-31 | 715.6 K | Susquehanna International Group, Llp | 2024-12-31 | 702.1 K | Two Sigma Investments Llc | 2024-12-31 | 700.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 669 K | Millennium Management Llc | 2024-12-31 | 668.1 K | Aristotle Capital Boston, Llc | 2024-12-31 | 648.8 K | Bank Of New York Mellon Corp | 2024-12-31 | 613.3 K | Blackrock Inc | 2024-12-31 | 4.5 M | Vanguard Group Inc | 2024-12-31 | 3.9 M |
Nu Skin Enterprises Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nu Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nu Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nu Skin insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nu Skin Outstanding Bonds
Nu Skin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nu Skin Enterprises uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NUS bonds can be classified according to their maturity, which is the date when Nu Skin Enterprises has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Nu Skin Corporate Filings
8K | 6th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 27th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 31st of January 2025 Other Reports | ViewVerify | |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.